Chengdu Kanghong Pharmaceuticals Group Co Ltd (002773.SZ) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE1000020C4

Price
19.70 CNY
Market cap
18.15 bn CNY
P/E (2025)
15.61
P/S (2025)
3.96
Dividend yield
3.55 %
Net margin
25.36 %
Return on equity (ROE)
12.51 %
Return on assets (ROA)
11.72 %

Chengdu Kanghong Pharmaceuticals Group Co Ltd financials

Fiscal year20242025
Revenue4.45 bn CNY4.59 bn CNY
Gross profit3.98 bn CNY4.12 bn CNY
Operating income1.38 bn CNY1.30 bn CNY
EBIT1.23 bn CNY1.30 bn CNY
Net income1.19 bn CNY1.16 bn CNY
Diluted EPS – continuing operations1.30 CNY1.26 CNY

Full history since 2009, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Chengdu Kanghong Pharmaceuticals Group Co Ltd

Chengdu Kanghong Pharmaceutical Group Co., Ltd engages in the research, development, manufacture, and sale of pharmaceuticals and medical devices in China. It develops medicines for ophthalmic, neuropsychiatric, and others. The company was founded in 1996 and is headquartered in Chengdu, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 23.10.2026. Details in the risk notice.